Largest pharmaceutical companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by earnings, at SAR 100.6B, ahead of Eli Lilly (SAR 77.4B) and Merck & Co (SAR 68.5B). Figures as of 20 Nov 2026, 12:11 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Johnson & JohnsonSAR 100.6B
- Median
- -SAR 179.2M
- Combined market value
- SAR 14.02T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SAR 100.6B | SAR 2.41T | SAR 1,002.28 | 2.04% down | 31% up | ||
| 2 | Eli LillyLLY · Health Care | SAR 77.4B | SAR 4.52T | SAR 5,069.27 | 2.29% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | SAR 68.5B | SAR 1.23T | SAR 498.29 | 3.61% down | 36% up | ||
| 4 | PfizerPFE · Health Care | SAR 29.2B | SAR 589B | SAR 103.33 | 1.85% down | 10% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | SAR 26.5B | SAR 447.4B | SAR 218.89 | 2.05% down | 26% up | ||
| 6 | Abbott LaboratoriesABT · Health Care | SAR 24.5B | SAR 675B | SAR 389.71 | 0.58% down | 19% down | ||
| 7 | Regeneron PharmaceuticalsREGN · Health Care | SAR 16.9B | SAR 358.4B | SAR 3,464.28 | 2.35% down | 22% up | ||
| 8 | AbbVieABBV · Health Care | SAR 15.9B | SAR 1.88T | SAR 1,063.81 | 0.86% down | 20% up | ||
| 9 | Vertex PharmaceuticalsVRTX · Health Care | SAR 14.8B | SAR 495.3B | SAR 1,953.46 | 2.94% down | 22% up | ||
| 10 | ZoetisZTS · Health Care | SAR 10B | SAR 123.2B | SAR 303.12 | 5.59% down | 34% down | ||
| 11 | United TherapeuticsUTHR · Health Care | SAR 5B | SAR 89.3B | SAR 2,097.69 | 3.16% down | 18% up | ||
| 12 | Royalty PharmaRPRX · Health Care | SAR 2.9B | SAR 146.1B | SAR 254.08 | 1.38% down | 74% up | ||
| 13 | PTC TherapeuticsPTCT · Health Care | SAR 2.6B | SAR 18.3B | SAR 218.83 | 3.16% down | 26% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | SAR 1.7B | SAR 36.8B | SAR 243.42 | 1.88% down | 103% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | SAR 1.3B | SAR 44.6B | SAR 230.44 | 0.02% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | SAR 1.2B | SAR 74.3B | SAR 554.61 | 1.06% down | 66% down | ||
| 17 | Ligand PharmaceuticalsLGND · Health Care | SAR 466.9M | SAR 21.5B | SAR 1,076.57 | 3.94% down | 44% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | SAR 373.9M | SAR 26.7B | SAR 243.80 | 4.15% down | 16% down | ||
| 19 | Amneal PharmaceuticalsAMRX · Health Care | SAR 270.4M | SAR 28B | SAR 80.25 | 2.24% down | 79% up | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | -SAR 6.1M | SAR 23.2B | SAR 163.77 | 1.25% up | 8% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | -SAR 87.7M | SAR 23.4B | SAR 358.34 | 3.27% up | 35% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | -SAR 95.8M | SAR 17.4B | SAR 181.22 | 3.86% down | 39% up | ||
| 23 | VeradermicsMANE · Health Care | -SAR 262.6M | SAR 19.7B | SAR 466.70 | 0.38% down | 230% up | ||
| 24 | Belite BioBLTE · Health Care | -SAR 291.2M | SAR 23B | SAR 566.61 | 3.33% down | 25% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -SAR 395.6M | SAR 24.8B | SAR 366.07 | 1.91% up | 233% up | ||
| 26 | ErascaERAS · Health Care | -SAR 467.3M | SAR 18.7B | SAR 53.35 | 3.34% up | 387% up | ||
| 27 | Protagonist TherapeuticsPTGX · Health Care | -SAR 488.3M | SAR 30.4B | SAR 465.31 | 2.47% down | 45% up | ||
| 28 | Spyre TherapeuticsSYRE · Health Care | -SAR 582.3M | SAR 34.8B | SAR 366.30 | 3.77% down | 302% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | -SAR 609.1M | SAR 17.9B | SAR 318.27 | 1.01% up | 105% up | ||
| 30 | Edgewise TherapeuticsEWTX · Health Care | -SAR 629.6M | SAR 16.9B | SAR 154.47 | 0.48% down | 82% up | ||
| 31 | Axsome TherapeuticsAXSM · Health Care | -SAR 687.3M | SAR 26.8B | SAR 509.06 | 1.25% up | 9% down | ||
| 32 | Definium TherapeuticsDFTX · Health Care | -SAR 689.6M | SAR 15.1B | SAR 110.61 | 1.24% up | 176% up | ||
| 33 | Rhythm PharmaceuticalsRYTM · Health Care | -SAR 737.4M | SAR 30.4B | SAR 438.22 | 1.88% down | 15% up | ||
| 34 | Elanco Animal HealthELAN · Health Care | -SAR 870.4M | SAR 49.3B | SAR 98.64 | 1.54% down | 18% up | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -SAR 1.1B | SAR 34.6B | SAR 1,488.53 | 0.34% down | 28% down | ||
| 36 | Legend BiotechLEGN · Health Care | -SAR 1.1B | SAR 11.7B | SAR 60.41 | 0.92% down | 43% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | -SAR 1.1B | SAR 32.6B | SAR 1,166.47 | 1.87% up | 83% up | ||
| 38 | Cogent BiosciencesCOGT · Health Care | -SAR 1.2B | SAR 18.1B | SAR 104.08 | 0.25% down | 25% down | ||
| 39 | Ionis PharmaceuticalsIONS · Health Care | -SAR 1.4B | SAR 17B | SAR 102.13 | 0.62% down | 64% down | ||
| 40 | BridgeBio PharmaBBIO · Health Care | -SAR 2.7B | SAR 57.1B | SAR 293.32 | 0.22% up | 15% up | ||
| 41 | CytokineticsCYTK · Health Care | -SAR 2.9B | SAR 26.9B | SAR 193.07 | 0.27% up | 21% down | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -SAR 4.1B | SAR 31.7B | SAR 39.66 | 0.67% up | 35% down | ||
| 43 | InsmedINSM · Health Care | -SAR 4.8B | SAR 118.9B | SAR 542.00 | 20.58% up | 27% down | ||
| 44 | ViatrisVTRS · Health Care | -SAR 13.2B | SAR 85.5B | SAR 74.59 | 1.97% down | 90% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7519 SAR).
Questions and answers
Which pharmaceutical companies in the United States rank first by earnings?
Johnson & Johnson (SAR 100.6B), Eli Lilly (SAR 77.4B) and Merck & Co (SAR 68.5B) are the top three of the 44 pharmaceutical companies in the United States ranked by earnings as of 20 Nov 2026, 12:11 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by earnings.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of SAR 14.02T as of 20 Nov 2026, 12:11 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.